Central African Republic vs Kazakhstan: Pneumococcal conjugate second or third-dose vaccines (PCVc)

Central African Republic
45.0%
in 2025
Kazakhstan
49.0%
in 2025
Central African Republic rank
158th
Kazakhstan rank
156th

Pneumococcal conjugate second or third-dose vaccines (PCVc) over time

  • Central African Republic
  • Kazakhstan
020406080200820162025

How they compare

Kazakhstan currently reports 49.0% against 45.0% in Central African Republic, a difference of 4.0%.

That makes Kazakhstan's figure about 1.1 times Central African Republic's.

The two have swapped places 2 times across 18 shared years of data; in 2008 it was Kazakhstan ahead.

Central African Republic ranks 158th and Kazakhstan ranks 156th of 194 countries.

Kazakhstan has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Central African Republic Kazakhstan Difference Ahead
2000s 0.0% 0.0% 0.0%
2010s 32.7% 51.4% 18.7% Kazakhstan
2020s 38.0% 50.8% 12.8% Kazakhstan

Averages of every year both report within each decade.

Frequently asked questions

Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Central African Republic or Kazakhstan?
Kazakhstan, at 49.0% against 45.0% in Central African Republic as of 2025.
What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Central African Republic and Kazakhstan?
4.0%, with Kazakhstan ahead.
How many years of comparable data are there for Central African Republic and Kazakhstan?
18 years are reported by both, from 2008 to 2025.
How do Central African Republic and Kazakhstan rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
Central African Republic ranks 158th and Kazakhstan ranks 156th of 194 countries.
Where does this data come from?
World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Central African Republic vs Kazakhstan: Pneumococcal conjugate second or third-dose vaccines (PCVc). Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 24 August 2026, from https://health.statizoid.com/compare/pneumococcal-conjugate-second-or-third-dose-vaccines-pcvc-immunization-coverage-by-the/central-african-republic/kazakhstan/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/pneumococcal-conjugate-second-or-third-dose-vaccines-pcvc-immunization-coverage-by-the/central-african-republic/kazakhstan/">Central African Republic vs Kazakhstan: Pneumococcal conjugate second or third-dose vaccines (PCVc)</a> — Statizoid

About this data

Indicator
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
206 places, 3,705 data points, 2008–2025
Last refreshed